Skip to content

A study to compare two different Homoeopathic potency treatments for Ringworm infections.

A Comparative Study of 50 Millesimal Potency over Centesimal Potency in Homoeopathic Management of Dermatophytosis - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096617
Enrollment
30
Registered
2025-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B35- Dermatophytosis

Interventions

Intervention1: A comparative study of 50 Millesimal potency over centre Simla potency in Homoeopathic management of dermatophytosis.: Homoeopathic medicines in 50 millesimal and centesimal potency wil

Sponsors

Dr Sheetal Kumawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of dermatophytosis infection 2.Age group : 5 to 55 years old 3.Patients willing giving consent

Exclusion criteria

Exclusion criteria: 1.Patient suffering from candiasis. 2.Patient who are consuming steroids tablets or applying steroidal cream from long period. 3. Patient not willing giving consent form

Design outcomes

Primary

MeasureTime frame
Outcome assessed with Clinical System score for both group individually. Improvement: If the score was reduced by 4 or more, after the treatment. Status Quo: If the score remained the same or was reduced by less than 4, after the treatment. Worse: If the score was increased even after the treatment.Timepoint: On alternative follow up which is to taken after every 20 days or as per need for period within 18 months.

Secondary

MeasureTime frame
MONARCH (Modified Naranjo Criteria)Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Sheetal Kumawat

Motiwala (National) Homoeopathic Medical College nd Hospital.

mhmc1@hotmail.com9822458231

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026